Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with Major Depression

[1]  H. M. Morris,et al.  GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. , 2011, The international journal of neuropsychopharmacology.

[2]  M. Webster,et al.  Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. , 2011, Journal of psychiatry & neuroscience : JPN.

[3]  E. Sibille,et al.  Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: Relevance to emotionality and sex , 2011, Journal of Neuroscience Methods.

[4]  E. Sibille,et al.  Reduced somatostatin in subgenual anterior cingulate cortex in major depression , 2011, Neurobiology of Disease.

[5]  R. Yuste,et al.  Dense Inhibitory Connectivity in Neocortex , 2011, Neuron.

[6]  S. Langenecker,et al.  Emotion processing, major depression, and functional genetic variation of neuropeptide Y. , 2011, Archives of general psychiatry.

[7]  N. Pivac,et al.  The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide. , 2011, Journal of affective disorders.

[8]  Etienne Sibille,et al.  Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism , 2011, Neurobiology of Disease.

[9]  Daniel S Pine,et al.  BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents , 2010, NeuroImage.

[10]  K. Sakata,et al.  Lack of promoter IV‐driven BDNF transcription results in depression‐like behavior , 2010, Genes, brain, and behavior.

[11]  B. Penninx,et al.  Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatment , 2010, Molecular Psychiatry.

[12]  M. Leboyer,et al.  A SNAP25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brain , 2010, Molecular Psychiatry.

[13]  C. Gaiteri,et al.  Altered Gene Synchrony Suggests a Combined Hormone-Mediated Dysregulated State in Major Depression , 2010, PloS one.

[14]  F. Holsboer,et al.  A novel chronic social stress paradigm in female mice , 2010, Hormones and Behavior.

[15]  Paul B. Fitzgerald,et al.  Evidence of Cortical Inhibitory Deficits in Major Depressive Disorder , 2010, Biological Psychiatry.

[16]  V. Carli,et al.  Increased BDNF promoter methylation in the Wernicke area of suicide subjects. , 2010, Archives of general psychiatry.

[17]  P. Czobor,et al.  Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[18]  C. Belzung,et al.  Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress , 2009, Behavioural Brain Research.

[19]  David A Lewis,et al.  A molecular signature of depression in the amygdala. , 2009, The American journal of psychiatry.

[20]  J. Deakin,et al.  Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. , 2009, Journal of psychiatric research.

[21]  E. Sibille,et al.  The roles of sex and serotonin transporter levels in age- and stress-related emotionality in mice , 2009, Brain Research.

[22]  W. Bunney,et al.  Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression , 2009, PloS one.

[23]  Kenji F. Tanaka,et al.  Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice. , 2009, The international journal of neuropsychopharmacology.

[24]  L. Monteggia,et al.  Gender-Specific Impact of Brain-Derived Neurotrophic Factor Signaling on Stress-Induced Depression-Like Behavior , 2009, Biological Psychiatry.

[25]  E. Cattaneo,et al.  Brain-derived neurotrophic factor in neurodegenerative diseases , 2009, Nature Reviews Neurology.

[26]  J. Hensler,et al.  Gender differences in the enhanced vulnerability of BDNF+/- mice to mild stress. , 2009, The international journal of neuropsychopharmacology.

[27]  E. Sibille,et al.  Corticolimbic Transcriptome Changes are State-Dependent and Region-Specific in a Rodent Model of Depression and of Antidepressant Reversal , 2009, Neuropsychopharmacology.

[28]  Keri Martinowich,et al.  Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex , 2009, Proceedings of the National Academy of Sciences.

[29]  C. Dickson,et al.  Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: Behavioral and neurophysiological evidence , 2008, Neuroscience.

[30]  R. Duman,et al.  Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.

[31]  H. M. Morris,et al.  Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. , 2008, Cerebral cortex.

[32]  J. P. Hamilton,et al.  Neural Substrates of Increased Memory Sensitivity for Negative Stimuli in Major Depression , 2008, Biological Psychiatry.

[33]  F. Broekmans,et al.  Relationship of serum antimüllerian hormone concentration to age at menopause. , 2008, The Journal of clinical endocrinology and metabolism.

[34]  E. Roubos,et al.  Gender-related urocortin 1 and brain-derived neurotrophic factor expression in the adult human midbrain of suicide victims with major depression , 2008, Neuroscience.

[35]  Ahmad R. Hariri,et al.  Genetic variation in human NPY expression affects stress response and emotion , 2008, Nature.

[36]  A. Meyer-Lindenberg,et al.  Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression , 2008, Molecular Psychiatry.

[37]  D. Lewis,et al.  Large-scale estimates of cellular origins of mRNAs: Enhancing the yield of transcriptome analyses , 2008, Journal of Neuroscience Methods.

[38]  Tamara Aid,et al.  Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters☆ , 2007, Genomics.

[39]  Peter F. Buckley,et al.  Neurotrophins and schizophrenia , 2007, Schizophrenia Research.

[40]  R Hen,et al.  Lack of serotonin1B receptor expression leads to age-related motor dysfunction, early onset of brain molecular aging and reduced longevity , 2007, Molecular Psychiatry.

[41]  F. Mascagni,et al.  Postsynaptic targets of somatostatin‐containing interneurons in the rat basolateral amygdala , 2007, The Journal of comparative neurology.

[42]  Serge Nef,et al.  Brain-Derived Neurotrophic Factor Conditional Knockouts Show Gender Differences in Depression-Related Behaviors , 2007, Biological Psychiatry.

[43]  M. Thase,et al.  Increased Amygdala and Decreased Dorsolateral Prefrontal BOLD Responses in Unipolar Depression: Related and Independent Features , 2007, Biological Psychiatry.

[44]  Wim E Crusio,et al.  Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice , 2006, Behavioural Brain Research.

[45]  D. Lewis,et al.  Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood , 2006, Molecular Psychiatry.

[46]  R. Duman,et al.  A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.

[47]  E. Nestler,et al.  Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action , 2006, Nature Neuroscience.

[48]  A. Børresen-Dale,et al.  Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy , 2006, Molecular Cancer Therapeutics.

[49]  Danielle L. Graham,et al.  Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress , 2006, Science.

[50]  M. Whitlock.  Combining probability from independent tests: the weighted Z‐method is superior to Fisher's approach , 2005, Journal of evolutionary biology.

[51]  M. Schwald,et al.  Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. , 2005, Brain research. Molecular brain research.

[52]  V. Arango,et al.  Molecular aging in human prefrontal cortex is selective and continuous throughout adult life , 2005, Biological Psychiatry.

[53]  J. Bizot,et al.  Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress , 2004, Behavioural Brain Research.

[54]  N. Schork,et al.  Candidate genes, pathways and mechanisms for bipolar (manic–depressive) and related disorders: an expanded convergent functional genomics approach , 2004, Molecular Psychiatry.

[55]  Stuart Maudsley,et al.  A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin , 2004, Ageing Research Reviews.

[56]  B. Ravnkilde,et al.  Hippocampal volume and depression: a meta-analysis of MRI studies. , 2004, The American journal of psychiatry.

[57]  M. Barrot,et al.  Essential role of brain-derived neurotrophic factor in adult hippocampal function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[58]  John H Krystal,et al.  Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. , 2004, Archives of general psychiatry.

[59]  Anthony R. McIntosh,et al.  Limbic–frontal circuitry in major depression: a path modeling metanalysis , 2004, NeuroImage.

[60]  Michael Marriott,et al.  Lower hippocampal volume in patients suffering from depression: a meta-analysis. , 2004, The American journal of psychiatry.

[61]  J. Price,et al.  Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes , 2004, Biological Psychiatry.

[62]  R Hashimoto,et al.  Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia , 2004, Molecular Psychiatry.

[63]  B. Zörner,et al.  Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. , 2004, Brain research. Molecular brain research.

[64]  R. Hen,et al.  Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.

[65]  Yogesh K. Dwivedi,et al.  Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. , 2003, Archives of general psychiatry.

[66]  A. Sampson,et al.  Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.

[67]  E. Castrén,et al.  Activation of the TrkB Neurotrophin Receptor Is Induced by Antidepressant Drugs and Is Required for Antidepressant-Induced Behavioral Effects , 2003, The Journal of Neuroscience.

[68]  J. Price,et al.  Low glial numbers in the amygdala in major depressive disorder , 2002, Biological Psychiatry.

[69]  R. Duman,et al.  Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression , 2002, The Journal of Neuroscience.

[70]  S. Fatemi,et al.  Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia , 2001, Neuroreport.

[71]  G. MacQueen,et al.  Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication , 2001, Biological Psychiatry.

[72]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[73]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[74]  R. Paylor,et al.  Impairment in motor learning of somatostatin null mutant mice , 2001, Brain Research.

[75]  R. Kerwin,et al.  Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. , 2001, Archives of general psychiatry.

[76]  L. Selemon,et al.  Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder , 2001, Biological Psychiatry.

[77]  D. Lewis,et al.  Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.

[78]  A. Sampson,et al.  Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. , 2000, Archives of general psychiatry.

[79]  Fahmeed Hyder,et al.  Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy , 1999 .

[80]  C. Cotman,et al.  Exercise, Antidepressant Medications, and Enhanced Brain Derived Neurotrophic Factor Expression , 1999, Neuropsychopharmacology.

[81]  F. Bloom,et al.  The Central 5-HT3 Receptor in CNS Disorders , 1998, Neurochemical Research.

[82]  L. Glantz,et al.  Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. , 1997, Archives of general psychiatry.

[83]  Yasuhisa Endo,et al.  Brain‐Derived Neurotrophic Factor Increases the Stimulation‐Evoked Release of Glutamate and the Levels of Exocytosis‐Associated Proteins in Cultured Cortical Neurons from Embryonic Rats , 1997, Journal of neurochemistry.

[84]  T Bonhoeffer,et al.  Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[85]  M J Campbell,et al.  An immunohistochemical characterization of somatostatin‐28 and somatostatin‐281–12 in monkey prefrontal cortex , 1986, The Journal of comparative neurology.

[86]  Denis Dooley,et al.  Atlas of the Human Brain. , 1971 .

[87]  Serum BDNF concentrations in major depressive disorder: state-trait issues, clinical features and pharmacological treatment , 2014 .

[88]  J. Ávila,et al.  Expression of Somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer's disease patients. , 2010, Journal of Alzheimer's disease : JAD.

[89]  Neil A. Ernst,et al.  Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. , 2009, Archives of general psychiatry.

[90]  R A Bryant,et al.  Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety , 2009, Molecular Psychiatry.

[91]  V. Dumeaux,et al.  Gene expression profiling in whole-blood samples from postmenopausal women exposed to hormone replacement therapy , 2005, Breast Cancer Research.

[92]  G F Mason,et al.  Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. , 1999, Archives of general psychiatry.

[93]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .